Shares of CohBar, Inc. (NASDAQ:CWBR – Get Free Report) traded up 6.7% during mid-day trading on Wednesday . The stock traded as high as $0.80 and last traded at $0.80. 6,600 shares were traded during trading, a decline of 97% from the average session volume of 258,404 shares. The stock had previously closed at $0.75. […]
CohBar, Inc. (NASDAQ:CWBR – Get Rating) dropped 5.6% during mid-day trading on Monday . The stock traded as low as $2.63 and last traded at $2.70. Approximately 637,202 shares changed hands during mid-day trading, an increase of 21% from the average daily volume of 525,257 shares. The stock had previously closed at $2.86. CohBar Stock […]
TAMPA, FL / ACCESSWIRE / May 30, 2023 / Morphogenesis, Inc. ("Morphogenesis"), a privately-held Phase 2/3 clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor microenvironment
Morphogenesis, Inc. entered into a stock purchase agreement for the gross proceeds of $15 million on May 23, 2023. The transaction included participation from returning investor CohBar, Inc.. |
Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of CohBar, Inc. and Morphogenesis, Inc. is fair to CohBar shareholders.
Halper Sadeh encourages CohBar. | May 23, 2023